Table 2 Treatment Outcomes
Variable | CHOP n = 108 | DA-EPOCH n = 12 | |
|---|---|---|---|
RESPONSE TO TREATMENT, n(%) | |||
Complete response (CR) | 29 (27) | 5 (42) | |
Partial response (PR) | 14 (13) | 2 (17) | |
Progressive disease (PD) | 15 (14) | 1 (8) | |
No response assessment | 50 (46) | 4 (33) | |
ADVERSE EVENTS | |||
Neutropenia, n(%) | 13 (12) | 2 (17) | |
Grade | < 2 | 0 | 0 |
3 | 6 (6) | 2 (17) | |
4 | 7 (6) | 0 (0) | |
Anaemia, n(%) | 13 (12) | 1 (8) | |
Grade | |||
< 2 | 4 (4) | 1 (8) | |
3 | 9(8) | 0(0) | |
Thrombocytopenia, n(%) | 7 (6) | 0 (0) | |
Grade | < 2 | 6(3) | 0(0) |
3 | 1(1) | 0(0) | |
Other Adverse Events, n(%) | 4 (3) | 0 (0) | |
Sepsis | 1 (1) | 0 (0) | |
Death | 0 (0) | 1 (8) | |
Hepatic Encephalopathy | 1 (1) | 0 (0) | |